These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 36447297)

  • 1. Methylation differences in Alzheimer's disease neuropathologic change in the aged human brain.
    Lang AL; Eulalio T; Fox E; Yakabi K; Bukhari SA; Kawas CH; Corrada MM; Montgomery SB; Heppner FL; Capper D; Nachun D; Montine TJ
    Acta Neuropathol Commun; 2022 Nov; 10(1):174. PubMed ID: 36447297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frequency of LATE neuropathologic change across the spectrum of Alzheimer's disease neuropathology: combined data from 13 community-based or population-based autopsy cohorts.
    Nelson PT; Brayne C; Flanagan ME; Abner EL; Agrawal S; Attems J; Castellani RJ; Corrada MM; Cykowski MD; Di J; Dickson DW; Dugger BN; Ervin JF; Fleming J; Graff-Radford J; Grinberg LT; Hokkanen SRK; Hunter S; Kapasi A; Kawas CH; Keage HAD; Keene CD; Kero M; Knopman DS; Kouri N; Kovacs GG; Labuzan SA; Larson EB; Latimer CS; Leite REP; Matchett BJ; Matthews FE; Merrick R; Montine TJ; Murray ME; Myllykangas L; Nag S; Nelson RS; Neltner JH; Nguyen AT; Petersen RC; Polvikoski T; Reichard RR; Rodriguez RD; Suemoto CK; Wang SJ; Wharton SB; White L; Schneider JA
    Acta Neuropathol; 2022 Jul; 144(1):27-44. PubMed ID: 35697880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple gene variants linked to Alzheimer's-type clinical dementia via GWAS are also associated with non-Alzheimer's neuropathologic entities.
    Katsumata Y; Shade LM; Hohman TJ; Schneider JA; Bennett DA; Farfel JM; ; Kukull WA; Fardo DW; Nelson PT
    Neurobiol Dis; 2022 Nov; 174():105880. PubMed ID: 36191742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterizing Apolipoprotein E ε4 Carriers and Noncarriers With the Clinical Diagnosis of Mild to Moderate Alzheimer Dementia and Minimal β-Amyloid Peptide Plaques.
    Monsell SE; Kukull WA; Roher AE; Maarouf CL; Serrano G; Beach TG; Caselli RJ; Montine TJ; Reiman EM
    JAMA Neurol; 2015 Oct; 72(10):1124-31. PubMed ID: 26302353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resistance and resilience to Alzheimer's disease pathology are associated with reduced cortical pTau and absence of limbic-predominant age-related TDP-43 encephalopathy in a community-based cohort.
    Latimer CS; Burke BT; Liachko NF; Currey HN; Kilgore MD; Gibbons LE; Henriksen J; Darvas M; Domoto-Reilly K; Jayadev S; Grabowski TJ; Crane PK; Larson EB; Kraemer BC; Bird TD; Keene CD
    Acta Neuropathol Commun; 2019 Jun; 7(1):91. PubMed ID: 31174609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alzheimer's disease.
    De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
    Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monoamine oxidase B is elevated in Alzheimer disease neurons, is associated with γ-secretase and regulates neuronal amyloid β-peptide levels.
    Schedin-Weiss S; Inoue M; Hromadkova L; Teranishi Y; Yamamoto NG; Wiehager B; Bogdanovic N; Winblad B; Sandebring-Matton A; Frykman S; Tjernberg LO
    Alzheimers Res Ther; 2017 Aug; 9(1):57. PubMed ID: 28764767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of Cognition and Dementia With Neuropathologic Changes of Alzheimer Disease and Other Conditions in the Oldest Old.
    Montine TJ; Corrada MM; Kawas C; Bukhari SA; White LR; Tian L; Cholerton B
    Neurology; 2022 Sep; 99(10):e1067-e1078. PubMed ID: 35705500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CRISPR/dCas9-Dnmt3a-mediated targeted DNA methylation of APP rescues brain pathology in a mouse model of Alzheimer's disease.
    Park H; Shin J; Kim Y; Saito T; Saido TC; Kim J
    Transl Neurodegener; 2022 Sep; 11(1):41. PubMed ID: 36109806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Age-related amyloid beta deposition in transgenic mice overexpressing both Alzheimer mutant presenilin 1 and amyloid beta precursor protein Swedish mutant is not associated with global neuronal loss.
    Takeuchi A; Irizarry MC; Duff K; Saido TC; Hsiao Ashe K; Hasegawa M; Mann DM; Hyman BT; Iwatsubo T
    Am J Pathol; 2000 Jul; 157(1):331-9. PubMed ID: 10880403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of human-like extracellular sortilin neuropathology in transgenic Alzheimer's disease model mice and macaques.
    Zhou FQ; Jiang J; Griffith CM; Patrylo PR; Cai H; Chu Y; Yan XX
    Alzheimers Res Ther; 2018 Apr; 10(1):40. PubMed ID: 29690919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human Alzheimer's disease gene expression signatures and immune profile in APP mouse models: a discrete transcriptomic view of Aβ plaque pathology.
    Rothman SM; Tanis KQ; Gandhi P; Malkov V; Marcus J; Pearson M; Stevens R; Gilliland J; Ware C; Mahadomrongkul V; O'Loughlin E; Zeballos G; Smith R; Howell BJ; Klappenbach J; Kennedy M; Mirescu C
    J Neuroinflammation; 2018 Sep; 15(1):256. PubMed ID: 30189875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BIIB042, a novel γ-secretase modulator, reduces amyloidogenic Aβ isoforms in primates and rodents and plaque pathology in a mouse model of Alzheimer's disease.
    Scannevin RH; Chollate S; Brennan MS; Snodgrass-Belt PA; Peng H; Xu L; Jung MY; Bussiere T; Arastu MF; Talreja T; Xin Z; Dunstan RW; Fahrer D; Rohde E; Dunah AW; Wang J; Kumaravel G; Taveras AG; Moore Arnold H; Rhodes KJ
    Neuropharmacology; 2016 Apr; 103():57-68. PubMed ID: 26690893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuropathology of Alzheimer's Disease.
    Trejo-Lopez JA; Yachnis AT; Prokop S
    Neurotherapeutics; 2022 Jan; 19(1):173-185. PubMed ID: 34729690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel presenilin 1 and 2 double knock-out cell line for in vitro validation of PSEN1 and PSEN2 mutations.
    Pimenova AA; Goate AM
    Neurobiol Dis; 2020 May; 138():104785. PubMed ID: 32032730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CpG and non-CpG Presenilin1 methylation pattern in course of neurodevelopment and neurodegeneration is associated with gene expression in human and murine brain.
    Monti N; Cavallaro RA; Stoccoro A; Nicolia V; Scarpa S; Kovacs GG; Fiorenza MT; Lucarelli M; Aronica E; Ferrer I; Coppedè F; Troen AM; Fuso A
    Epigenetics; 2020 Aug; 15(8):781-799. PubMed ID: 32019393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amyloid Beta-Mediated Hypomethylation of Heme Oxygenase 1 Correlates with Cognitive Impairment in Alzheimer's Disease.
    Sung HY; Choi BO; Jeong JH; Kong KA; Hwang J; Ahn JH
    PLoS One; 2016; 11(4):e0153156. PubMed ID: 27058954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parallel profiling of DNA methylation and hydroxymethylation highlights neuropathology-associated epigenetic variation in Alzheimer's disease.
    Smith AR; Smith RG; Pishva E; Hannon E; Roubroeks JAY; Burrage J; Troakes C; Al-Sarraj S; Sloan C; Mill J; van den Hove DL; Lunnon K
    Clin Epigenetics; 2019 Mar; 11(1):52. PubMed ID: 30898171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alzheimer's disease amyloid-β pathology in the lens of the eye.
    Moncaster JA; Moir RD; Burton MA; Chadwick O; Minaeva O; Alvarez VE; Ericsson M; Clark JI; McKee AC; Tanzi RE; Goldstein LE
    Exp Eye Res; 2022 Aug; 221():108974. PubMed ID: 35202705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Soluble amyloid beta levels are elevated in the white matter of Alzheimer's patients, independent of cortical plaque severity.
    Collins-Praino LE; Francis YI; Griffith EY; Wiegman AF; Urbach J; Lawton A; Honig LS; Cortes E; Vonsattel JP; Canoll PD; Goldman JE; Brickman AM
    Acta Neuropathol Commun; 2014 Aug; 2():83. PubMed ID: 25129614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.